Patient Reported Symptom Control With THC or CBD Use
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 200
- 试验地点
- 2
- 主要终点
- Proportion of patients who prefer opioids with THC-marijuana and/or opioids with cannabidiol (CBD) to opioids alone for their cancer pain relief
研究概览
简要总结
This study compares patients' attitudes regarding marijuana products for medical use and other treatments for cancer-related pain. This study may help researchers gain better understanding of patient's perception on their use of marijuana products in treating cancer-related pain and other common cancer-related symptoms.
详细描述
PRIMARY OBJECTIVE:
I. To determine the patient's reported preference for cancer pain improvement with opioids, opioids with delta-9-tetrahydrocannabinol (THC)-marijuana and/or opioids with cannabidiol (CBD).
SECONDARY OBJECTIVES:
I. To determine the association between perception of cancer-related symptom relief and use of THC-marijuana and/or CBD.
II. To compare patient perception of THC-marijuana and/or CBD versus (vs.) cancer treatments in treatment of cancer.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients (inpatient or outpatient) seen by the Palliative Care and Integrative Medicine teams at The University of Texas MD Anderson Cancer Center (Texas) and the Palliative Care team at Banner MD Anderson Cancer Center (Arizona)
- •Patients must be primary residents of Texas or Arizona
- •Patients able to speak and read English
- •Patients are 18 years old and above
- •Patients should have a cancer diagnosis, cancer-associated pain, and taking strong opioids (morphine, oxycodone, hydrocodone, hydromorphone, oxymorphone, methadone, fentanyl)
- •Patients who have used in the past 3 months or are using alternative botanical pain management while under prescription opioids
排除标准
- •Patients who are not able to speak or read English
- •Altered mental status as determined by the interviewer based on the ability to understand the nature of the study and consent process
- •Patients who have not used medical marijuana and/or CBD products
- •Patients who do not have cancer
- •Patients who do not have cancer-associated pain
- •Patients who are not taking opioids
研究组 & 干预措施
Observational (medical record review, questionnaires))
Patients' medical records are reviewed and then complete questionnaires over 27 minutes.
干预措施: Electronic Health Record Review (Other)
Observational (medical record review, questionnaires))
Patients' medical records are reviewed and then complete questionnaires over 27 minutes.
干预措施: Questionnaire Administration (Other)
结局指标
主要结局
Proportion of patients who prefer opioids with THC-marijuana and/or opioids with cannabidiol (CBD) to opioids alone for their cancer pain relief
时间窗: through study completion, an average of 1 year
Will be calculated and reported along with a 95% confidence interval.
次要结局
- Perception of cancer-related symptom relief(through study completion, an average of 1 year)
- To evaluate patient report of adverse effects experienced while using THC-marijuana and/or CBD(through study completion, an average of 1 year)
- To evaluate patient reported concerns while using THC-marijuana and/or CBD(through study completion, an average of 1 year)
- To explore the difference of patient perception of THC-marijuana and CBD in cancer centers in a legalized vs. a non-legalized state.(through study completion, an average of 1 year)
- Patient perception of THC-marijuana and/or CBD(through study completion, an average of 1 year)
- Patient attitude of dosing, forms and use of THC-marijuana and/or CBD(through study completion, an average of 1 year)
- Demographic, physical and psychosocial factors that influence patient perception and attitudes of THC-marijuana and/or CBD(through study completion, an average of 1 year)
- Patient reported preference of THC-Marijuana and CBD for cancer pain and symptom relief of patients(through study completion, an average of 1 year)